GNE-7915 is primarily utilized in the field of medical research, particularly in the study of neurodegenerative diseases. It functions as a potent and selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), an enzyme implicated in the pathogenesis of Parkinson's disease. By inhibiting LRRK2, GNE-7915 helps researchers understand the role of this enzyme in disease progression and explore potential therapeutic strategies. Its application extends to preclinical studies where it is used to model Parkinson's disease in cellular and animal systems, aiding in the identification of biomarkers and the development of targeted treatments. Additionally, GNE-7915 serves as a valuable tool in pharmacological studies to assess the safety and efficacy of LRRK2 inhibition, contributing to the advancement of precision medicine in neurology.